Ultrasound Soft Markers of Aneuploidy
On this page
Direct answer
Ultrasound soft markers of aneuploidy are minor sonographic variants that are not malformations but modestly raise the chance of a chromosomal abnormality, most often Down syndrome. The main markers are increased nuchal fold thickness, echogenic bowel, echogenic intracardiac focus, short femur and pyelectasis. A single isolated marker shifts risk little, whereas several together shift it meaningfully and prompt an offer of karyotype testing.
What you must remember
- Nuchal fold: thickness of 6 mm or more in the second trimester is the most significant soft marker and a strong indicator of Down syndrome.
- Echogenic bowel: bowel as bright as iliac bone; it is also seen in cystic fibrosis, congenital infection and growth restriction, so its aneuploidy effect is modest.
- Echogenic intracardiac focus: a bright spot in the heart that is common in normal fetuses and adds only a small increment of risk.
- Short femur: femur length below the fifth centile for gestation, a weak marker on its own that matters mainly in combination.
- Pyelectasis: a mild renal pelvic dilatation, often transient and benign, but additive when other markers are present.
- Counselling: combine markers with maternal age and screening results, then offer karyotype or cell-free DNA testing rather than acting on a soft marker alone.
How each marker moves the risk
Second-trimester anatomy scans detect these variants in many normal pregnancies. The useful question is how far each one moves the risk, so markers are read together rather than one at a time.
| Marker | What is seen | Effect on aneuploidy risk |
|---|---|---|
| Nuchal fold | Thickened posterior neck fold, 6 mm or more | Strongest of the group |
| Echogenic bowel | Bowel as bright as iliac bone | Modest, with cystic fibrosis and infection also possible |
| Echogenic intracardiac focus | Bright focus in the ventricle | Small, and common in normal fetuses |
| Short femur | Femur below the fifth centile | Weak alone, adds to other markers |
| Pyelectasis | Renal pelvis about 4 mm or more | Small, often benign |
| Absent nasal bone | No nasal bone on the 11 to 14 week scan | Useful first-trimester marker |
Two or more markers, or a thick nuchal fold with an echogenic focus, justify a full aneuploidy discussion. The gestational age at the scan and the maternal age-based risk shape how far each finding moves the estimate.
Where the exam tries to catch you
Vignettes give one marker and then test whether the student escalates or reassures correctly.
- Trap: terminating a pregnancy on a single soft marker. Correct: an isolated soft marker adds little risk, so any decision needs a confirmed karyotype and the MTP Act framework.
- Trap: treating echogenic bowel as proof of aneuploidy. Correct: it is also linked to cystic fibrosis, congenital infection and growth restriction.
- Trap: calling all pyelectasis pathological. Correct: mild pyelectasis is often transient and benign, though it adds to combined risk.
- Trap: ignoring first-trimester markers. Correct: nuchal translucency and nasal bone assessed at 11 to 14 weeks feed the combined screen.
Frequently asked questions
What is the most significant soft marker of Down syndrome on second-trimester ultrasound?
Increased nuchal fold thickness is the most significant second-trimester soft marker of Down syndrome, with 6 mm or more commonly used as the threshold. It is read alongside other markers, maternal age and screening results before counselling.
Does an isolated echogenic intracardiac focus need invasive testing?
An isolated echogenic intracardiac focus does not usually need invasive testing, because it is common in normal fetuses and adds little risk. The Down syndrome risk rises only slightly and is judged better with other findings.
Can a soft marker alone justify termination of pregnancy?
A soft marker alone cannot justify termination of pregnancy, because it is a variant with only a small effect on risk. Any decision must follow a confirmed karyotype, and termination in India is governed by the MTP Act and its amendments.
Why is echogenic bowel not specific for Down syndrome?
Echogenic bowel is not specific for Down syndrome because it is also linked to cystic fibrosis, congenital infection and fetal growth restriction. Its association with aneuploidy is modest, so the finding prompts a search for other causes.